Swedish biotech company Empros Pharma is discontinuing its obesity drug programme. Difficulties in securing funding and ...

Swedish biotech company AnaCardio has raised €62.5 million, equivalent to more than SEK 700 million, in its largest funding round to date. “It’s a big day for us,” says Patrik Strömberg, the company’s ...

After years of success with the injection based Wegovy, Novo has released it in pill form in a wide range of countries – but ...

A successful Phase III trial in age-related macular degeneration sent shares in US-based Kodiak Sciences soaring on Monday.

Cinclus Pharma, which is developing new therapies for acid-related diseases, has now completed all planned patient visits in ...

MEMBER ANNOUNCEMENT - Many innovative therapies and medical technologies face the same challenge: you know a clinical study ...

Merck & Co has signed a licensing agreement worth up to $2.13 billion for global rights to a preclinical cancer drug ...

Swedish Egetis Therapeutics has secured FDA approval for its rare disease drug Emcitate, clearing the way for a US launch ...

Patients had localised pancreatic cancer but were not eligible for surgery. Following high-dose, MRI-guided radiotherapy with ...

German pharmaceutical company Biontech will close its facilities in Tübingen, Marburg and Idar-Oberstein after failing to ...

An Alzheimer’s research project led by associate professor Sebastian Palmqvist at Lund University has been awarded 19.4 ...

Tavapadon, marketed under the brand name Juvmo, has been given the green light by the US Food and Drug Administration (FDA).